Zofingen, Switzerland

Ulrich Jahn

This inventor holds 13 USPTO granted patents, primarily in Pharmaceutical Chemistry. Top assignees: Siegfried Aktiengesellschaft, Siegfried Aktiengesselschaft. Active years: 1976-1987.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ulrich Jahn. Retrieved from https://idiyas.com/inventor/ulrich-jahn

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 4

Forward Citations = 66(Granted Patents)


Company Filing History:


Years Active: 1976-1987

Loading Chart...
Areas of Expertise:
Theophylline Derivatives
Antihypertensive Compounds
Xanthine Oxidase Inhibitor
Cholesterol-Lowering
Phenoxy Alkanoic Acids
Indazole Derivatives
Lipid Lowering
Pharmacological Activity
Pyridyl Alkyl Esters
Novel Compounds
Chlorobenzyl Phenoxy
Alkylene Glycols
13 patents (USPTO):Explore Patents

Title: Ulrich Jahn: Innovator in Theophylline Derivatives

Introduction

Ulrich Jahn is a notable inventor based in Zofingen, Switzerland. He has made significant contributions to the field of pharmaceuticals, particularly in the development of theophylline derivatives. With a total of 13 patents to his name, Jahn's work has had a considerable impact on medical science.

Latest Patents

Among his latest patents, Jahn has developed new derivatives of theophylline that exhibit various pharmacological properties. One of his notable inventions includes P-fluorobenzoyl-piperidino alkyl theophylline derivatives. These compounds demonstrate histamine-serotonin-bradykinin antagonistic, anti-anaphylactic, and β-adrenergic stimulating effects. Another significant patent involves theophylline derivatives characterized by specific chemical formulas, which also show similar beneficial properties.

Career Highlights

Throughout his career, Ulrich Jahn has worked with prominent companies in the pharmaceutical industry, including Siegfried Aktiengesellschaft. His expertise in medicinal chemistry has allowed him to contribute to the development of innovative therapeutic agents.

Collaborations

Jahn has collaborated with notable professionals in his field, including Kurt Thiele and Rudolf Adrian. These partnerships have further enhanced his research and development efforts.

Conclusion

Ulrich Jahn's contributions to the field of pharmaceuticals, particularly through his innovative theophylline derivatives, highlight his role as a significant inventor. His work continues to influence medical research and therapeutic advancements.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…